Clinical trials
Completed Phase 1/2 Autistic Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Boston Children's Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Chugani, Diane C. | 1 |
| Federal University of São Paulo | 1 |
| Nambudripad's Allergy Research Foundation | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Shenzhen Beike Bio-Technology Co., Ltd. | 1 |
| Southwest College of Naturopathic Medicine | 1 |
| State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autistic Disorder | 14 |
| Asperger Syndrome | 3 |
| Autism Spectrum Disorder | 3 |
| Child Development Disorders, Pervasive | 2 |
| Anxiety Disorders | 1 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
| Food Hypersensitivity | 1 |
| Hamartoma Syndrome, Multiple | 1 |
| Intellectual Disability | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.